Your Journey to a Better You Starts Here

Peptides are short chains of amino acids — the same building blocks that make up proteins. Peptides are generally 2 to 50 amino acids long; longer chains are classified as proteins. Your body produces thousands of peptides naturally as signaling molecules, hormones, and regulators of biological processes.

Examples you may already know: insulin (regulates blood sugar), oxytocin (social bonding), and growth hormone (widely discussed in the peptide community). In research contexts, "peptides" usually means synthetic versions sold as lyophilized (freeze-dried) powders.

Peptides bind to specific receptors on or inside cells, triggering a biological response — like a key fitting a lock. GHRP-6 binds ghrelin receptors to trigger GH release; semaglutide binds GLP-1 receptors affecting insulin and appetite; BPC-157 interacts with tissue repair pathways.

Each peptide has a specific target, active dose range, and half-life. Dosage protocols matter because the wrong dose, frequency, or route may produce no effect, a different effect, or unwanted side effects.

Research peptides arrive as lyophilized powder in a glass vial with rubber stopper and crimp cap. The label shows peptide name and total amount (e.g. "BPC-157 5mg"). Powder must be reconstituted before use — dry form is far more stable than liquid.

What you need: peptide vial, bacteriostatic water (BAC), insulin syringe (U-100), alcohol swabs.

1. Swab both vial stoppers with alcohol.
2. Draw BAC water into syringe (volume sets concentration).
3. Inject slowly against the glass wall — not directly onto powder.
4. Swirl gently — never shake. Most dissolve in 1–2 minutes.
5. Refrigerate immediately after reconstitution.

mg / mcg: 1 mg = 1,000 mcg. Some peptides dose in mg (semaglutide), others in mcg (Ipamorelin).

Syringe units: On a U-100 syringe, 100 units = 1 mL. Each unit = 0.01 mL — volume marks, not dose marks.

IU: Biological potency for HGH and HCG. Not the same as syringe units.

The default for most protocols. Inject into fatty tissue beneath the skin — lower abdomen, thigh, or upper arm. Reliable absorption, simple technique, short insulin needles.

Some peptides (HCG, certain GH protocols) specify IM — directly into muscle. Slightly longer needle, faster absorption than SubQ.

Most peptides have poor oral bioavailability. Exceptions include oral semaglutide (Rybelsus), MK-677 (oral GH secretagogue), and some BPC-157 oral research. Nasal administration is less common in standard protocols.

No universal side effect profile — each compound has its own risks. Common themes: injection site reactions, headaches, nausea. GH peptides may cause water retention or glucose changes. GLP-1 agonists often cause GI effects. Each protocol page includes peptide-specific safety notes.

More is not better. Peptides have dose-response curves where effectiveness plateaus and side effects increase. Following evidence-based ranges — not forum megadosing — is the most important risk-reduction step.

Research peptides are not FDA-regulated. A vendor COA does not equal pharmaceutical QC. Purity, sterility, and labeling accuracy are not guaranteed outside regulated pharmacy systems.

Some peptides are prescription drugs (semaglutide, HGH). Others sit in legal gray areas as research chemicals. Performance peptides are prohibited by WADA for tested athletes. Read full disclaimers →